British officials: Virus variant may be deadlier
CDC expects it to become dominant strain in US by March
LONDON – British Prime Minister Boris Johnson warned Friday that a coronavirus variant first detected in the country in September may be about 30% more deadly than previous versions of the disease.
British scientists already had concluded that the variant spread 30%-70% faster than the previous dominant coronavirus strain in the U.K.
In addition to spreading faster, “it may be associated with a higher degree of mortality,” Johnson said.
Patrick Vallance, Johnson’s chief scientific adviser, explained the previous average death rate of 60-year-olds in Britain from COVID-19 was about 10 per 1,000. With the new variant, roughly 13 or 14 out of 1,000 infected people might be expected to die, he said.
“I want to stress there’s a lot of uncertainty around these numbers, and we need more work to get a precise handle on it, but it obviously is a concern that this (variant) has an increase in mortality as well as an increase in transmissibility,” Vallance said.
The conclusions were based on findings provided to the British government by the New and Emerging Respiratory Virus Threats Advisory
Group, or NERVTAG. The group compared mortality rates in people infected with new and old versions of the virus.
The announcement marked the first time British officials said the variant, discovered in Kent, England, appeared more lethal. They previously said there was no reason to believe it could make people sicker or lead to more fatalities.
The findings were based on two papers presented Jan. 15 that showed an increased case fatality rate across age groups. The NERVTAG summary found a “realistic possibility” that infection with the variant “is associated with an increased risk of death compared to infection with the non-VOC (virus of concern) viruses.”
The summary emphasized that the hospital case fatality rate associated with the variant has not increased, and “the absolute risk of death per infection remains low.”
Hospitalization rates have not increased, according to the report, although that data may lag death rates.
The study was based on the deaths of 2,583 people – 384 of whom had the variant – among 1.2 million tested. This represents about 8% of all deaths in the U.K. during the study period of late November to early January.
Research suggests the Pfizer-BioNTech and Oxford-AstraZeneca vaccines will continue to be effective against the variant in the U.K., which has spread around the world, including the USA.
The Centers for Disease Control and Prevention said in a report it expects the fast-spreading variant to become the dominant strain in the USA by March, potentially fueling exponential growth of the disease.
As of Jan. 20, the CDC reported 144 cases of the variant in the USA.
Luciana Borio, a COVID-19 adviser to the Biden administration and former official with the Food and Drug Administration, said it’s too early to say the variant directly leads to more deaths.
As more people are infected, more are expected to die, and “the quality of medical care degrades when the system is under tremendous stress as it is right now in the U.K.,” she said.
Borio said there may be more deaths because people are avoiding or unable to get routine care during the pandemic.
Akiko Iwasaki, an immunologist at Yale University, said the news should encourage people to “double-down” on their efforts to stay safe through maskwearing, avoiding indoor crowding and getting vaccinated as soon they have access.